EUVIMEDEUVIMED entdecken
Open Access

Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy

Muhammad Kalim, Rui Jing, Xin Li, Zhiwu Jiang, Ningbo Zheng, Ziyu Wang, Guo Wei, Yong Lu

Journal of Cellular Immunology · 2024 · 6 (1) · 22-50

DOI: 10.33696/immunology.6.189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Immunology, 2024. Verfasst von Muhammad Kalim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist Cancer Center/Weill Cornell Medicine, Houston, TX 77030, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR)-T cell therapy has shown potential in improving outcomes for individuals with hematological malignancies. However, achieving long-term full remission for blood cancer remains challenging due to severe life-threatening toxicities such as limited anti-tumor efficacy, antigen escape, trafficking restrictions, and limited tumor invasion. Furthermore, the interactions between CAR-T cells and their host tumor microenvironments have a significant impact on CAR-T function. To overcome these considerable hurdles, fresh methodologies and approaches are needed to produce more powerful CAR-T cells with greater anti-tumor activity and less toxicity. Despite advances in CAR-T research, microbial resistance remains a significant obstacle. In this review, we discuss and describe the basics of CAR-T structures, generations, challenges, and potential risks of infections in CAR-T cell therapy.

Schlagwörter

Stichwörter der Autor:innen

Adoptive cellular therapyCAR-TCOVID-19ImmunotherapyInfection

Autor:innen und Institutionen

  • Houston Methodist Cancer Center/Weill Cornell Medicine, Houston, TX 77030, USA.
  • Department of Microbiology & Immunology, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Kalim, M., Jing, R., Li, X., Jiang, Z., Zheng, N., Wang, Z., Wei, G., & Lu, Y. (2024). Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy. Journal of Cellular Immunology, 6(1), 22-50. https://doi.org/10.33696/immunology.6.189

Vancouver

Kalim M, Jing R, Li X, Jiang Z, Zheng N, Wang Z, et al. Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy. Journal of Cellular Immunology. 2024;6(1):22-50. doi:10.33696/immunology.6.189

BibTeX
@article{Kalim2024,
  author = {Kalim, Muhammad and Jing, Rui and Li, Xin and Jiang, Zhiwu and Zheng, Ningbo and Wang, Ziyu and Wei, Guo and Lu, Yong},
  title = {Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy},
  journal = {Journal of Cellular Immunology},
  year = {2024},
  volume = {6},
  number = {1},
  pages = {22--50},
  doi = {10.33696/immunology.6.189}
}
Kostenlos starten →